Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1996;94:718-726

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hwang, K.-C.
Right arrow Articles by Im, M.-J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hwang, K.-C.
Right arrow Articles by Im, M.-J.

(Circulation. 1996;94:718-726.)
© 1996 American Heart Association, Inc.


Articles

{alpha}1-Adrenergic Receptor Coupling With Gh in the Failing Human Heart

Ki-Chul Hwang, PhD; Caroline D. Gray, MS; Wendy E. Sweet, BS; Christine S. Moravec, PhD; Mie-Jae Im, PhD

the Department of Molecular Cardiology and Center for Anesthesiology Research (W.E.S., C.S.M.), Research Institute, the Cleveland (Ohio) Clinic Foundation.

Correspondence to Mie-Jae Im, PhD, Department of Molecular Cardiology (FFB-37), Research Institute, the Cleveland Clinic Foundation, 9500 Euclid Ave, Cleveland, OH 44195.

Background We recently demonstrated that Gh, which transfers the signal from the {alpha}1-adrenergic receptor to the 69-kD phospholipase C, is the previously identified tissue-type transglutaminase (TGase II). The {alpha}1-adrenergic receptor mediates actions of the sympathetic nervous system, including cardiac, arteriolar, and smooth muscle contractions. In human cardiac tissue, the expression of the {alpha}1-adrenergic receptor is increased under pathophysiological conditions, but changes in the physiological response are small. Therefore, it has been suggested that the other components involved in the {alpha}1-adrenergic receptor–mediated signaling pathway are probably altered.

Methods and Results Immunological and biochemical studies with nonfailing and failing human heart tissues revealed that the GTP-binding and TGase activities of human heart TGase II (hhG{alpha}h) are downregulated in both ischemic and dilated cardiomyopathic human heart. In ischemic cardiomyopathy, the {alpha}1-adrenergic receptor number increased twofold (27.0 fmol/mg) compared with the nonfailing (12.8 fmol/mg) and the dilated cardiomyopathic (15.6 fmol/mg) heart tissues, but the coupling of hhG{alpha}h with the {alpha}1-adrenergic receptor did not increase. The intrinsic activity of hhG{alpha}h was greatly decreased in membrane fractions, whereas the cytosolic TGase activity was not changed. In the dilated cardiomyopathic human heart, these intrinsic enzyme activities of hhG{alpha}h were also downregulated in the membrane fraction, whereas the amount of hhG{alpha}h protein was greatly increased (2.8-fold) compared with the nonfailing heart.

Conclusions The results of the present study clearly demonstrate that the {alpha}1-adrenergic receptor in human heart couples with Gh (TGase II) and indicate that downregulation of hhG{alpha}h activity is associated with human cardiac failure but that the mechanism differs between ischemic and dilated cardiomyopathies.


Key Words: heart failure • receptors, adrenergic, alpha • transglutaminase II • proteins • signal transduction




This article has been cited by other articles:


Home page
J BiochemHome page
K. Y. Chae, J.-H. Kim, W.-J. Park, Y.-G. Kim, H.-Y. Yun, N. S. Kwon, M.-J. Im, and K. J. Baek
Distinct pH Modulation for Dual Function of G{alpha}h (Transglutaminase II)
J. Biochem., March 1, 2005; 137(3): 407 - 413.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. K. Kang, K. S. Yi, N. S. Kwon, K.-H. Park, U.-H. Kim, K. J. Baek, and M.-J. Im
{alpha}1B-Adrenoceptor Signaling and Cell Motility: GTPase FUNCTION OF Gh/TRANSGLUTAMINASE 2 INHIBITS CELL MIGRATION THROUGH INTERACTION WITH CYTOPLASMIC TAIL OF INTEGRIN {alpha} SUBUNITS
J. Biol. Chem., August 27, 2004; 279(35): 36593 - 36600.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
S. E. Iismaa and R. M. Graham
Dissecting Cardiac Hypertrophy and Signaling Pathways: Evidence for an Interaction Between Multifunctional G Proteins and Prostanoids
Circ. Res., May 30, 2003; 92(10): 1059 - 1061.
[Full Text] [PDF]


Home page
Circ. Res.Home page
Z. Zhang, R. Vezza, T. Plappert, P. McNamara, J. A. Lawson, S. Austin, D. Pratico, M. S.-J. Sutton, and G. A. FitzGerald
COX-2-Dependent Cardiac Failure in Gh/tTG Transgenic Mice
Circ. Res., May 30, 2003; 92(10): 1153 - 1161.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
A. Ziegelhoffer, P. S Tappia, N. Mesaeli, N. Sahi, N. S Dhalla, and V. Panagia
Low level of sarcolemmal phosphatidylinositol 4,5-bisphosphate in cardiomyopathic hamster (UM-X7.1) heart
Cardiovasc Res, January 1, 2001; 49(1): 118 - 126.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
O.-E. Brodde and M. C. Michel
Adrenergic and Muscarinic Receptors in the Human Heart
Pharmacol. Rev., December 1, 1999; 51(4): 651 - 690.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Small, J.-F. Feng, J. Lorenz, E. T. Donnelly, A. Yu, M.-J. Im, G. W. Dorn II, and S. B. Liggett
Cardiac Specific Overexpression of Transglutaminase II (Gh) Results in a Unique Hypertrophy Phenotype Independent of Phospholipase C Activation
J. Biol. Chem., July 23, 1999; 274(30): 21291 - 21296.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
P. S. Tappia, S.-Y. Liu, S. Shatadal, N. Takeda, N. S. Dhalla, and V. Panagia
Changes in sarcolemmal PLC isoenzymes in postinfarct congestive heart failure: partial correction by imidapril
Am J Physiol Heart Circ Physiol, July 1, 1999; 277(1): H40 - H49.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
J. L. McDonough, D. K. Arrell, and J. E. Van Eyk
Troponin I Degradation and Covalent Complex Formation Accompanies Myocardial Ischemia/Reperfusion Injury
Circ. Res., January 22, 1999; 84(1): 9 - 20.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Zhang, M. Lesort, R. P. Guttmann, and G. V. W. Johnson
Modulation of the in Situ Activity of Tissue Transglutaminase by Calcium and GTP
J. Biol. Chem., January 23, 1998; 273(4): 2288 - 2295.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
G. L. Stiles
Multifunctional G Proteins: Searching for Functions in the Heart
Circulation, August 15, 1996; 94(4): 602 - 603.
[Full Text]


Home page
J. Biol. Chem.Home page
N. Nanda, S. E. Iismaa, W. A. Owens, A. Husain, F. Mackay, and R. M. Graham
Targeted Inactivation of Gh/Tissue Transglutaminase II
J. Biol. Chem., June 1, 2001; 276(23): 20673 - 20678.
[Abstract] [Full Text] [PDF]